CEFOTAXIME SODIUM SALT; Sodium cefotaxime; Tolycar; Pretor; (+)-Cefotaxime sodium salt; Cefotaxime (sodium salt); HR 756; C16H16N5NaO7S2; UNII-258J72S7TZ; Cefotaxime sodium salt (syn-isomer); MFCD00079073; RU 24756; MLS000028559; 258J72S7TZ; Sodium 7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)cephalosporanate; HR-756; Cefotax; SMR000058812; Ralopar; Tolycor; Zariviz; Claforan sodium; MLS002222330; Cefotaxim sodium salt; CEFOTAXIME NA-SALT; SMR001307269; Cefotaxim sodium; Claforan (TN); Prestwick_823; Cefotaxime sodium [USAN:USP:JAN]; EINECS 264-915-9; Ru-24756; Cefotaxime, Sodium Salt; Opera_ID_1945; CHEMBL1010; SCHEMBL41092; Cefotaxime and dextrose 2.4% in plastic container; Cefotaxime and dextrose 3.9% in plastic container; MLS001077352; MLS001333684; CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER; Cefotaxime sodium (JP17/USP); DTXSID4046991; CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER; HMS1568K20; HMS2095K20; HMS2233J21; HMS3260H18; HMS3712K20; HY-A0088; Tox21_500278; 63527-52-6 (acid); s4517; AKOS015951272; CCG-220139; CCG-221582; CS-4297; KS-1416; NCGC00093734-01; NCGC00093734-02; NCGC00260963-01; SMR000653480; EU-0100278; A16005; C 7912; C08113; D00919; J10142; Cefadroxil, Antibiotic for Culture Media Use Only; Q-200807; Cefotaxime sodium salt, potency: 916-964 mug per mg; Cefotaxime sodium, European Pharmacopoeia (EP) Reference Standard; Cefotaxime sodium salt, plant cell culture tested, BioReagent, powder; Cefotaxime sodium, United States Pharmacopeia (USP) Reference Standard